Literature DB >> 28832950

Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia.

Nice Turazzi1, Grazia Fazio1, Valentina Rossi1, Antonius Rolink2, Giovanni Cazzaniga1, Andrea Biondi1, Chiara F Magnani1, Ettore Biagi1.   

Abstract

Entities:  

Keywords:  B-cell acute lymphoblastic leukaemia (B-ALL); TNFRSF13C (BAFF-R); chimeric antigen receptor (CAR); tumour immunotherapy

Mesh：

Substances：

Year:  2017        PMID： 28832950     DOI： 10.1111/bjh.14899

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.

Authors:  Hong Qin; Zhenyuan Dong; Xiuli Wang; Wesley A Cheng; Feng Wen; Weili Xue; Han Sun; Miriam Walter; Guowei Wei; D Lynne Smith; Xiuhua Sun; Fan Fei; Jianming Xie; Theano I Panagopoulou; Chun-Wei Chen; Joo Y Song; Ibrahim Aldoss; Clarisse Kayembe; Luisa Sarno; Markus Müschen; Giorgio G Inghirami; Stephen J Forman; Larry W Kwak
Journal:  Sci Transl Med       Date:  2019-09-25       Impact factor: 17.956

Review 2.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

3.  Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.

Authors:  Chiara F Magnani; Giuseppe Gaipa; Federico Lussana; Daniela Belotti; Giuseppe Gritti; Sara Napolitano; Giada Matera; Benedetta Cabiati; Chiara Buracchi; Gianmaria Borleri; Grazia Fazio; Silvia Zaninelli; Sarah Tettamanti; Stefania Cesana; Valentina Colombo; Michele Quaroni; Giovanni Cazzaniga; Attilio Rovelli; Ettore Biagi; Stefania Galimberti; Andrea Calabria; Fabrizio Benedicenti; Eugenio Montini; Silvia Ferrari; Martino Introna; Adriana Balduzzi; Maria Grazia Valsecchi; Giuseppe Dastoli; Alessandro Rambaldi; Andrea Biondi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma.

Authors:  Xiaolan Zhou; Matthias Mulazzani; Iven-Alex von Mücke-Heim; Sigrid Langer; Wenlong Zhang; Hellen Ishikawa-Ankerhold; Martin Dreyling; Andreas Straube; Louisa von Baumgarten
Journal:  Front Oncol       Date:  2020-05-27       Impact factor: 6.244

Review 5.  Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments.

Authors:  Xinjie Xu; Shengkang Huang; Xinyi Xiao; Qihang Sun; Xiaoqian Liang; Sifei Chen; Zijing Zhao; Zhaochang Huo; Sanfang Tu; Yuhua Li
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

6.  Peripheral Blood Biomarkers CXCL12 and TNFRSF13C Associate with Cerebrospinal Fluid Biomarkers and Infiltrating Immune Cells in Alzheimer Disease.

Authors:  Qianqian Wu; Wei Kong; Shuaiqun Wang
Journal:  J Mol Neurosci       Date:  2021-03-09       Impact factor: 3.444
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.